LONDON, UK – International Health Partners (IHP) is excited to announce a new partnership with Orion, the globally operating Finnish pharmaceutical company that specialises in areas including neurological disorders, oncology and respiratory diseases.

The partnership will see Orion donate a range of essential medicines including antibiotics and anti-inflammatories. An initial shipment of 10,000 units of antibiotics will be sent to the Central African Republic, followed by a shipment of almost 40,000 units of essential medication to Haiti.

Working closely with NGOs in-country, IHP is able to facilitate and respond to the specific medical needs of the most vulnerable communities who would otherwise have limited or no access to this kind of medicine.

Adele Paterson, CEO of International Health Partners, said: “We are so excited about this partnership with Orion. In Europe, we often take for granted the ease with which we can access the medicines we need. But for millions of people around the world, getting hold of even basic medication such as antibiotics or pain relief is unattainable. Through generous donations like this, we can ensure pharmacies and clinics in underserved communities around the world remain stocked, so that everyone can have access to good healthcare.”

Noora Paronen, Head of Corporate Responsibility, Orion, said: “We have been ensuring that patients get the needed medicines, especially in our domestic market for over a hundred years already. It is amazing that through this partnership we can provide medicines for those in need in vulnerable communities too. Without this partnership, many of these medicines, which although well within date, would be destroyed due to changes in demand. We’re delighted to have been able to find a good use for these Orion antibiotics and painkillers to help people in need.”

 -ENDS-

For further information about IHP please contact Hazel Brearley at [email protected] or call (020) 3735 5489

 

www.ihpuk.org

 

Notes to editors:

About International Health Partners:

International Health Partners (IHP) is a global health NGO based in the UK. IHP supports people in disaster-hit and vulnerable communities to get the medicines they need, by coordinating the safe and responsible donation of long-dated medical products. Working with its strong network of global healthcare partners, IHP sources and sends treatments to help people around the world.

IHP responds rapidly to humanitarian disasters, supports long-term healthcare development projects and equips medics with supplies to carry out their work. IHP is the largest coordinator of donated medical products in Europe. As an independent intermediary, it bridges the gap between healthcare companies and humanitarian agencies, helping individuals and communities access essential medicines and health supplies.

 

About Orion Pharma

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2020 amounted to EUR 1,078 million and the company had about 3,300 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.